chronic insomnia disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meets CI diagnostic criteria; 2. Pittsburgh Sleep Quality Index (PSQI) total score greater than or equal to 8; 3. Age between 18 and 75 years, regardless of gender; 4. Signed informed consent form; Patients must meet all four of the above criteria to be eligible for the study.
Exclusion criteria
Exclusion criteria: 1. History of mental illness, epilepsy, or cognitive impairment; 2. Women who are breastfeeding and/or have a positive urine pregnancy test; 3. Currently using medications that affect autonomic nervous function, such as ß-blockers, anticholinergic drugs, etc.; 4. Presence of contraindications to TMS such as cochlear implants, cardiac pacemakers, or metallic implants in the brain; 5. Skin allergies or ear infections that make taVNS and rTMS interventions unsuitable; 6. Long-term use of insomnia-related medications or use within one month prior to treatment; 7. Individuals deemed unsuitable for participation in the clinical trial by the investigator; Any person who meets any of the above criteria cannot be included in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Brain-Computer Interface Related Indicators;Functional Near-Infrared Spectroscopy Related Indicators;Resting motor threshold;Autonomic Nervous Function Indicators;Insomnia Severity Index;Hamilton Anxiety Rating Scale;Hamilton Depression Rating Scale ;Epworth Sleepiness Scale;Flinders Fatigue Scale; | — |
Countries
China
Contacts
Guangdong Provincial Hospital of Chinese Medicine